Background illustration for clinical trials search

Paid Clinical Trials Killeen

Discover 680 paid clinical trials in Killeen, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Waco TX, Austin TX, DeSoto TX, Arlington TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221227

Phase3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Waco TX, Bryan TX, Dallas TX, Wylie TX, Allen TX,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase3, Recruiting

A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for the Identification of Acute Opioid Use Events and the Quantification of Opioid Withdrawal in Opioid Dependent Individuals

for
Treatment for Opioid Use Disorder
Location: Cedar Park TX, Austin TX, Wilmington NC
Sponsor: OpiAID

Sex: All

Age: 22+

Code: NCT07405398

Recruiting

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

for
Atopic Dermatitis
Location: Cedar Park TX, Dallas TX, Hollywood FL, Grapevine TX,
Sponsor: Galderma R&D

Sex: All

Age: 12+

Code: NCT06988605

Recruiting

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

for
Ulcerative Colitis
Location: Cedar Park TX, Houston TX, Kansas City KS,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18 - 70+

Code: NCT06636656

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

for
Inflammatory Bowel Diseases, Crohn's Disease
Location: Cedar Park TX, Mansfield TX, Lewisville TX, Tyler TX,
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

Sex: All

Age: 18 - 70+

Code: NCT06226883

Phase2, Recruiting

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

for
Crohn's Disease
Location: Cedar Park TX, Mansfield TX, San Antonio TX,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06045754

Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for
Clostridium Difficile, Clostridium Difficile Infections,
Location: Cedar Park TX, Dallas TX, Lubbock TX, New Orleans LA,
Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase3, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Waco TX, Houston TX, Kansas City KS, Birmingham AL,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase1, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Waco TX, Austin TX, Fort Lauderdale FL, Fort Worth TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase3, Recruiting

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer,
Location: Waco TX, Austin TX, Irving TX, The Woodlands TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07421700

Phase1, Phase2, Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: Waco TX, Fredericksburg TX, Dallas TX, Houston TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07276399

Phase3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Waco TX, Austin TX, Fort Worth TX, Dallas TX,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase3, Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma,
Location: Waco TX, Austin TX, Irving TX, The Woodlands TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07227415

Phase1, Phase2, Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Waco TX, Austin TX, San Antonio TX, Bedford TX,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for
Cervical Cancer
Location: Waco TX, Austin TX, Fort Worth TX, Dallas TX,
Sponsor: Pfizer

Sex: Female

Age: 18+

Code: NCT06952660

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Round Rock TX, Fort Worth TX, Kingwood TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase3, Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

for
Non-small Cell Lung Cancer,
Location: Round Rock TX, Houston TX, Nashville TN, Gilbert AZ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05877599

Phase1, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Round Rock TX, Fort Worth TX, Irving TX, Palestine TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase3, Recruiting

Maestro 1.1 Post-Market Registry

for
Surgery
Location: Cedar Park TX, Denver CO, Jacksonville FL, Orlando FL,
Sponsor: Moon Surgical

Sex: All

Age: 18 - 70+

Code: NCT06103136

Recruiting